{"id":578793,"date":"2021-12-13T08:56:01","date_gmt":"2021-12-13T08:56:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=578793"},"modified":"2021-12-13T08:56:01","modified_gmt":"2021-12-13T08:56:01","slug":"periodontal-disease-market-epidemiology-and-market-forecast-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/periodontal-disease-market-epidemiology-and-market-forecast-2030_578793.html","title":{"rendered":"Periodontal Disease Market, Epidemiology and Market Forecast – 2030"},"content":{"rendered":"
\n
\"Periodontal<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cPeriodontal Disease Market\u201c report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

Periodontal Disease Market<\/strong><\/p>\n

The Periodontal Disease market report <\/a>provides current treatment practices, emerging drugs, Periodontal Disease market share of the individual therapies, current and forecasted Periodontal Disease market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Periodontal Disease treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.<\/p>\n

Periodontal Disease Market Outlook<\/strong><\/p>\n

The Periodontal Disease market outlook <\/a>of the report helps to build the detailed comprehension of the historic, current, and forecasted Periodontal Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.<\/p>\n

This segment gives a thorough detail of Periodontal Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.<\/p>\n

According to DelveInsight, Periodontal Disease market in 7MM is expected to change in the study period 2017-2030.<\/p>\n

Request for sample pages @ Periodontal Disease Market Forecast<\/a> <\/strong><\/p>\n

Table of contents<\/strong><\/p>\n

1. Key Insights<\/p>\n

2. Executive Summary of Periodontal Disease<\/p>\n

3. Competitive Intelligence Analysis for Periodontal Disease<\/p>\n

4. Periodontal Disease: Market Overview at a Glance<\/p>\n

4.1. Periodontal Disease Total Market Share (%) Distribution in 2017<\/p>\n

4.2. Periodontal Disease Total Market Share (%) Distribution in 2030<\/p>\n

5. Periodontal Disease: Disease Background and Overview<\/p>\n

5.1. Introduction<\/p>\n

5.2. Sign and Symptoms<\/p>\n

5.3. Pathophysiology<\/p>\n

5.4. Risk Factors<\/p>\n

5.5. Diagnosis<\/p>\n

6. Patient Journey<\/p>\n

7. Periodontal Disease Epidemiology and Patient Population<\/p>\n

7.1. Epidemiology Key Findings<\/p>\n

7.2. Assumptions and Rationale: 7MM<\/p>\n

7.3. Epidemiology Scenario: 7MM<\/p>\n

7.3.1. Periodontal Disease Epidemiology Scenario in the 7MM (2017-2030)<\/p>\n

7.4. United States Epidemiology<\/p>\n

7.4.1. Periodontal Disease Epidemiology Scenario in the United States (2017-2030)<\/p>\n

7.5. EU-5 Country-wise Epidemiology<\/p>\n

7.5.1. Germany Epidemiology<\/p>\n

7.5.1.1. Periodontal Disease Epidemiology Scenario in Germany (2017-2030)<\/p>\n

7.5.2. France Epidemiology<\/p>\n

7.5.2.1. Periodontal Disease Epidemiology Scenario in France (2017-2030)<\/p>\n

7.5.3. Italy Epidemiology<\/p>\n

7.5.3.1. Periodontal Disease Epidemiology Scenario in Italy (2017-2030)<\/p>\n

7.5.4. Spain Epidemiology<\/p>\n

7.5.4.1. Periodontal Disease Epidemiology Scenario in Spain (2017-2030)<\/p>\n

7.5.5. United Kingdom Epidemiology<\/p>\n

7.5.5.1. Periodontal Disease Epidemiology Scenario in the United Kingdom (2017-2030)<\/p>\n

7.5.6. Japan Epidemiology<\/p>\n

7.5.6.1. Periodontal Disease Epidemiology Scenario in Japan (2017-2030)<\/p>\n

8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n

8.1. Periodontal Disease Treatment and Management<\/p>\n

8.2. Periodontal Disease Treatment Algorithm<\/p>\n

9. Unmet Needs<\/p>\n

10. Key Endpoints of Periodontal Disease Treatment<\/p>\n

11. Marketed Products<\/p>\n

11.1. List of Marketed Products in the 7MM<\/p>\n

11.2. Drug Name: Company Name<\/p>\n

11.2.1. Product Description<\/p>\n

11.2.2. Regulatory Milestones<\/p>\n

11.2.3. Other Developmental Activities<\/p>\n

11.2.4. Pivotal Clinical Trials<\/p>\n

11.2.5. Summary of Pivotal Clinical Trial<\/p>\n

List to be continued in report<\/p>\n

12. Emerging Therapies<\/p>\n

12.1. Key Cross<\/p>\n

12.2. Drug Name: Company Name<\/p>\n

12.2.1. Product Description<\/p>\n

12.2.2. Other Developmental Activities<\/p>\n

12.2.3. Clinical Development<\/p>\n

12.2.4. Safety and Efficacy<\/p>\n

12.2.5. Product Profile<\/p>\n

List to be continued in report<\/p>\n

13. Periodontal Disease: Seven Major Market Analysis<\/p>\n

13.1. Key Findings<\/p>\n

13.2. Periodontal Disease Market Size in 7MM<\/p>\n

13.3. Periodontal Disease Market Size by Therapies in the 7MM<\/p>\n

14. Attribute analysis<\/p>\n

15. 7MM: Market Outlook<\/p>\n

15.1. United States: Market Size<\/p>\n

15.1.1. Periodontal Disease Total Market Size in the United States<\/p>\n

15.1.2. Periodontal Disease Market Size by Therapies in the United States<\/p>\n

15.2. EU-5 countries: Market Size and Outlook<\/p>\n

15.3. Germany Market Size<\/p>\n

15.3.1. Periodontal Disease Total Market Size in Germany<\/p>\n

15.3.2. Periodontal Disease Market Size by Therapies in Germany<\/p>\n

15.4. France Market Size<\/p>\n

15.4.1. Periodontal Disease Total Market Size in France<\/p>\n

15.4.2. Periodontal Disease Market Size by Therapies in France<\/p>\n

15.5. Italy Market Size<\/p>\n

15.5.1. Periodontal Disease Total Market Size in Italy<\/p>\n

15.5.2. Periodontal Disease Market Size by Therapies in Italy<\/p>\n

15.6. Spain Market Size<\/p>\n

15.6.1. Periodontal Disease Total Market Size in Spain<\/p>\n

15.6.2. Periodontal Disease Market Size by Therapies in Spain<\/p>\n

15.7. United Kingdom Market Size<\/p>\n

15.7.1. Periodontal Disease Total Market Size in the United Kingdom<\/p>\n

15.7.2. Periodontal Disease Market Size by Therapies in the United Kingdom<\/p>\n

15.8. Japan Market Outlook<\/p>\n

15.8.1. Japan Market Size<\/p>\n

15.8.2. Periodontal Disease Total Market Size in Japan<\/p>\n

15.8.3. Periodontal Disease Market Size by Therapies in Japan<\/p>\n

16. Access and Reimbursement Overview of Periodontal Disease<\/p>\n

17. KOL Views<\/p>\n

18. Market Drivers<\/p>\n

19. Market Barriers<\/p>\n

20. Appendix<\/p>\n

20.1. Bibliography<\/p>\n

20.2. Report Methodology<\/p>\n

21. DelveInsight Capabilities<\/p>\n

22. Disclaimer<\/p>\n

23. About DelveInsight<\/p>\n

*The table of contents is not exhaustive; the final content may vary. <\/em><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight<\/a>
Contact Person:<\/strong> Priya Maurya
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +919650213330
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Albany
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight Business Research LLP DelveInsight\u2019s \u201cPeriodontal Disease Market\u201c report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-578793","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/578793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=578793"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/578793\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=578793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=578793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=578793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}